Cargando…

Autophagy in Cancer Therapy

Autophagy represents a catabolic program involved in the degradation of cellular components via lysosomes. It serves to mitigate cellular stress and to provide metabolic precursors especially upon starvation. Thereby, autophagy can support the survival of cancer cells. In addition, there is now conv...

Descripción completa

Detalles Bibliográficos
Autor principal: Fulda, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475391/
https://www.ncbi.nlm.nih.gov/pubmed/28674677
http://dx.doi.org/10.3389/fonc.2017.00128
_version_ 1783244555530797056
author Fulda, Simone
author_facet Fulda, Simone
author_sort Fulda, Simone
collection PubMed
description Autophagy represents a catabolic program involved in the degradation of cellular components via lysosomes. It serves to mitigate cellular stress and to provide metabolic precursors especially upon starvation. Thereby, autophagy can support the survival of cancer cells. In addition, there is now convincing evidence showing that under certain conditions autophagy can also foster cell death. This dual function of autophagy is also relevant upon anticancer treatment, as many chemotherapeutic agents engage autophagy. A better understanding of the molecular mechanisms that are critical for mediating autophagic cell death in cancer cells will be instrumental to selectively interfere with this cellular program in order to increase the cancer cell’s response to cytotoxic drugs. This review illustrates how anticancer drug-induced autophagy is involved in mediating cell death.
format Online
Article
Text
id pubmed-5475391
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54753912017-07-03 Autophagy in Cancer Therapy Fulda, Simone Front Oncol Oncology Autophagy represents a catabolic program involved in the degradation of cellular components via lysosomes. It serves to mitigate cellular stress and to provide metabolic precursors especially upon starvation. Thereby, autophagy can support the survival of cancer cells. In addition, there is now convincing evidence showing that under certain conditions autophagy can also foster cell death. This dual function of autophagy is also relevant upon anticancer treatment, as many chemotherapeutic agents engage autophagy. A better understanding of the molecular mechanisms that are critical for mediating autophagic cell death in cancer cells will be instrumental to selectively interfere with this cellular program in order to increase the cancer cell’s response to cytotoxic drugs. This review illustrates how anticancer drug-induced autophagy is involved in mediating cell death. Frontiers Media S.A. 2017-06-15 /pmc/articles/PMC5475391/ /pubmed/28674677 http://dx.doi.org/10.3389/fonc.2017.00128 Text en Copyright © 2017 Fulda. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Fulda, Simone
Autophagy in Cancer Therapy
title Autophagy in Cancer Therapy
title_full Autophagy in Cancer Therapy
title_fullStr Autophagy in Cancer Therapy
title_full_unstemmed Autophagy in Cancer Therapy
title_short Autophagy in Cancer Therapy
title_sort autophagy in cancer therapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475391/
https://www.ncbi.nlm.nih.gov/pubmed/28674677
http://dx.doi.org/10.3389/fonc.2017.00128
work_keys_str_mv AT fuldasimone autophagyincancertherapy